Aurion Biotech (@AurionBiotech) header
Aurion Biotech (@AurionBiotech) profile picture

Aurion Biotech

@AurionBiotech

Transformational platform of advanced therapies to cure blindness

Joined June 2021
  • Tweets65
  • Following36
  • Followers91
14Media
Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)Photo by Aurion Biotech (@AurionBiotech)
Great companies are led by great people. Congrats to @gregkunst and thanks to @PSBJ for this Healthcare Leadership award! bizjournals.com/seattle/news…
He's on a quest to use cell therapy to combat eye disease

He's on a quest to use cell therapy to combat eye disease

Aurion Biotech's CEO shares his company's breakthrough.

bizjournals.com
532
So proud that we have received this honor! aurionstaging.wpengine.com/a…
Image from Aurion Biotech (@AurionBiotech)
3
642
Edward J. Holland, MD, and Shigeru Kinoshita, MD, PhD, discuss the U.S. phase 1/2 trial for @AurionBiotech's AURN001 #celltherapy for #cornealedema, which was invented by Kinoshita and just dosed its first patient last month. Find out more 🔗: bit.ly/40teAnt
1
1
2
700
Terrific conversation on challenges of C&GT manufacturing in a changing world. #cgmesa2023
Image from Aurion Biotech (@AurionBiotech)
1
244
Greg Kunst shares the Aurion Biotech story on cell therapy for endothelial corneal disease ⁦@OSNNewYork⁩
Image from Ocular Surgery News (@Healio_OSN)
1
1
3
357
Great companies, in great company! Honored for Aurion to share BioFuture Stage with @endpts @leileiwuu, Sean Ainsworth @Immusoft, Christine Silverstein @ExcisionBio, Liz Wood @JuraBio to talk about the future of cell and gene therapy: how it will transform patient care.
Image from Aurion Biotech (@AurionBiotech)
2
2
314
Dr. Matt Giegengack presenting Escalon trial 12-month data here at ASCRS
Image from Aurion Biotech (@AurionBiotech)
1
224
ASCRS Live: Aurion BioTech shares 12-month data from our recent Escalón trial ophthalmologytimes.com/view/…
ASCRS Live: Aurion BioTech shares 12-month data from their recent Escalón trial | Eye Care Network...

ASCRS Live: Aurion BioTech shares 12-month data from their recent Escalón trial | Eye Care Network...

Ophthalmology Times© spoke with Greg Kunst about Aurion BioTech's 12-month data from their recent Escalón trial 2023 at the ASCRS annual meeting in San Diego.

ophthalmologytimes.com
150
please that our chief scientific officer asked to speak to CGTLive! ow.ly/WaKp50O1kKc
Arnaud Lacoste, PhD, on AURN001‘s Immunomodulatory Properties | CGTlive®

Arnaud Lacoste, PhD, on AURN001‘s Immunomodulatory Properties | CGTlive®

The chief scientific officer of Aurion Biotech discussed the properties of the cell therapy for corneal dystrophies, which was recently approved in Japan.

cgtlive.com
1
109
Aurion Biotech retweeted
CGTLive® (@CGT_Live) profile picture
CGTLive®@CGT_Live28 Apr 2023
Lacoste discussed the findings of the research @AurionBiotech presented at #ARVO2023, noting that the study provided evidence that AURN001 cells contribute to immune privilege in the anterior chamber of the eye. Watch now: ow.ly/WaKp50O1kKc
Arnaud Lacoste, PhD, on AURN001‘s Immunomodulatory Properties | CGTlive®

Arnaud Lacoste, PhD, on AURN001‘s Immunomodulatory Properties | CGTlive®

The chief scientific officer of Aurion Biotech discussed the properties of the cell therapy for corneal dystrophies, which was recently approved in Japan.

cgtlive.com
1
1
2
177
Congrats to our inspiring inventor, Prof Shigeru Kinoshita, for being named to the Power List!urldefense.proofpoint.com/v2…
2
132
Terrific panel at Reuters Pharma USA 2023!
Image from Aurion Biotech (@AurionBiotech)
1
109
Important milestone for millions of patients suffering from corneal endothelial disease aurionbiotech.com/aurion-bio…
Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application - Aurion Biotech

Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application - Aurion Biotech

First approval in the world forallogeneic cell therapy to treat corneal endothelial disease March 23, 2023 – Seattle, Cambridge MA and Tokyo – Aurion Biotech, whose mission is to restore vision to...

aurionbiotech.com
1
2
3
900
Excited that Jon Sparks, JD, PhD joins Aurion as Chief Legal Officer! aurionbiotech.com/jonathan-s…
Arnaud Lacoste, Chief Scientific Officer at @AurionBiotech talks about the new cell therapy for corneal endothelial dystrophy and its potential to change corneal surgery 👀 bit.ly/3Mr8Ljj
1
1
Congrats to the 2022 #PrixGalien “Best Startup in Pharmaceutical or Biotechnology Industry” winner @AurionBiotech for its patented cell therapy treatment for corneal endothelial disease. Learn more: galien.org/3TNl3FH
Image from The Galien Foundation (@GalienFdn)
1
1
1
.@AurionBiotech wins Prix Galien Award for corneal endothelial dystrophy cell therapy. bit.ly/3DWOtvv #PrixGalienAward #celltherapy #Ophthalmology #OncularNews
2
3
We are hiring! Please join our fab company: fantastic people who are committed to restoring vision to patients with our life-changing cell therapy, fantastic locations (Seattle and Cambridge, MA), fantastic comp. What's not to love? aurionbiotech.com/open-posit…
Great things can happen when people work well together. aurionbiotech.com/living-our…
Honored by our affiliation with these two OWL nominees for Visionary Leader - Jeannette Bankes, Aurion board member, and Eric Donnenfeld, MD, Aurion medical advisory board member. Congrats, you two! owlsite.org/about-owl/2022-o…
Load more